341 related articles for article (PubMed ID: 33374779)
1. Habitual FODMAP Intake in Relation to Symptom Severity and Pattern in Patients with Irritable Bowel Syndrome.
Nybacka S; Störsrud S; Lindqvist HM; Törnblom H; Simrén M; Winkvist A
Nutrients; 2020 Dec; 13(1):. PubMed ID: 33374779
[TBL] [Abstract][Full Text] [Related]
2. Low fermentable oligo-di-mono-saccharides and polyols diet versus general dietary advice in patients with diarrhea-predominant irritable bowel syndrome: A randomized controlled trial.
Zahedi MJ; Behrouz V; Azimi M
J Gastroenterol Hepatol; 2018 Jun; 33(6):1192-1199. PubMed ID: 29159993
[TBL] [Abstract][Full Text] [Related]
3. Long-term irritable bowel syndrome symptom control with reintroduction of selected FODMAPs.
Harvie RM; Chisholm AW; Bisanz JE; Burton JP; Herbison P; Schultz K; Schultz M
World J Gastroenterol; 2017 Jul; 23(25):4632-4643. PubMed ID: 28740352
[TBL] [Abstract][Full Text] [Related]
4. Nutrient Intake, Diet Quality, and Diet Diversity in Irritable Bowel Syndrome and the Impact of the Low FODMAP Diet.
Staudacher HM; Ralph FSE; Irving PM; Whelan K; Lomer MCE
J Acad Nutr Diet; 2020 Apr; 120(4):535-547. PubMed ID: 31029650
[TBL] [Abstract][Full Text] [Related]
5. A diet low in FODMAPs reduces symptoms of irritable bowel syndrome.
Halmos EP; Power VA; Shepherd SJ; Gibson PR; Muir JG
Gastroenterology; 2014 Jan; 146(1):67-75.e5. PubMed ID: 24076059
[TBL] [Abstract][Full Text] [Related]
6. Multivariate modelling of faecal bacterial profiles of patients with IBS predicts responsiveness to a diet low in FODMAPs.
Bennet SMP; Böhn L; Störsrud S; Liljebo T; Collin L; Lindfors P; Törnblom H; Öhman L; Simrén M
Gut; 2018 May; 67(5):872-881. PubMed ID: 28416515
[TBL] [Abstract][Full Text] [Related]
7. Low FODMAP diet reduces gastrointestinal symptoms in irritable bowel syndrome and clinical response could be predicted by symptom severity: A randomized crossover trial.
Algera JP; Demir D; Törnblom H; Nybacka S; Simrén M; Störsrud S
Clin Nutr; 2022 Dec; 41(12):2792-2800. PubMed ID: 36384081
[TBL] [Abstract][Full Text] [Related]
8. Fermentable oligo-, di-, monosaccharides, and polyols (FODMAPs), but not gluten, elicit modest symptoms of irritable bowel syndrome: a double-blind, placebo-controlled, randomized three-way crossover trial.
Nordin E; Brunius C; Landberg R; Hellström PM
Am J Clin Nutr; 2022 Feb; 115(2):344-352. PubMed ID: 34617561
[TBL] [Abstract][Full Text] [Related]
9. IBS randomized study: FODMAPs alter bile acids, phenolic- and tryptophan metabolites, while gluten modifies lipids.
Nordin E; Hellström PM; Vuong E; Ribbenstedt A; Brunius C; Landberg R
Am J Physiol Regul Integr Comp Physiol; 2023 Sep; 325(3):R248-R259. PubMed ID: 37399002
[TBL] [Abstract][Full Text] [Related]
10. A Diet Low in FODMAPs Reduces Symptoms in Patients With Irritable Bowel Syndrome and A Probiotic Restores Bifidobacterium Species: A Randomized Controlled Trial.
Staudacher HM; Lomer MCE; Farquharson FM; Louis P; Fava F; Franciosi E; Scholz M; Tuohy KM; Lindsay JO; Irving PM; Whelan K
Gastroenterology; 2017 Oct; 153(4):936-947. PubMed ID: 28625832
[TBL] [Abstract][Full Text] [Related]
11. Randomised clinical trial: low-FODMAP rye bread vs. regular rye bread to relieve the symptoms of irritable bowel syndrome.
Laatikainen R; Koskenpato J; Hongisto SM; Loponen J; Poussa T; Hillilä M; Korpela R
Aliment Pharmacol Ther; 2016 Sep; 44(5):460-70. PubMed ID: 27417338
[TBL] [Abstract][Full Text] [Related]
12. Low fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAP) diet improves symptoms in adults suffering from irritable bowel syndrome (IBS) compared to standard IBS diet: A meta-analysis of clinical studies.
Varjú P; Farkas N; Hegyi P; Garami A; Szabó I; Illés A; Solymár M; Vincze Á; Balaskó M; Pár G; Bajor J; Szűcs Á; Huszár O; Pécsi D; Czimmer J
PLoS One; 2017; 12(8):e0182942. PubMed ID: 28806407
[TBL] [Abstract][Full Text] [Related]
13. A Randomized Controlled Trial Comparing the Low FODMAP Diet vs. Modified NICE Guidelines in US Adults with IBS-D.
Eswaran SL; Chey WD; Han-Markey T; Ball S; Jackson K
Am J Gastroenterol; 2016 Dec; 111(12):1824-1832. PubMed ID: 27725652
[TBL] [Abstract][Full Text] [Related]
14. Feasibility of Low Fermentable Oligosaccharide, Disaccharide, Monosaccharide, and Polyol Diet and Its Effects on Quality of Life in an Italian Cohort.
Cingolani A; Paduano D; Vecchiarelli V; Demelas M; Corrias PT; Casula L; Usai P
Nutrients; 2020 Mar; 12(3):. PubMed ID: 32182648
[TBL] [Abstract][Full Text] [Related]
15. Low-FODMAP Diet for Irritable Bowel Syndrome: What We Know and What We Have Yet to Learn.
Liu J; Chey WD; Haller E; Eswaran S
Annu Rev Med; 2020 Jan; 71():303-314. PubMed ID: 31986083
[TBL] [Abstract][Full Text] [Related]
16. Adherence to diet low in fermentable carbohydrates and traditional diet for irritable bowel syndrome.
Clevers E; Tran M; Van Oudenhove L; Störsrud S; Böhn L; Törnblom H; Simrén M
Nutrition; 2020 May; 73():110719. PubMed ID: 32086111
[TBL] [Abstract][Full Text] [Related]
17. Comparison of symptom response following advice for a diet low in fermentable carbohydrates (FODMAPs) versus standard dietary advice in patients with irritable bowel syndrome.
Staudacher HM; Whelan K; Irving PM; Lomer MC
J Hum Nutr Diet; 2011 Oct; 24(5):487-95. PubMed ID: 21615553
[TBL] [Abstract][Full Text] [Related]
18. The Impact of a 4-Week Low-FODMAP and mNICE Diet on Nutrient Intake in a Sample of US Adults with Irritable Bowel Syndrome with Diarrhea.
Eswaran S; Dolan RD; Ball SC; Jackson K; Chey W
J Acad Nutr Diet; 2020 Apr; 120(4):641-649. PubMed ID: 31103370
[TBL] [Abstract][Full Text] [Related]
19. Low fermentable oligosaccharide, disaccharide, monosaccharide, and polyol diet in patients with diarrhea-predominant irritable bowel syndrome: A prospective, randomized trial.
Goyal O; Batta S; Nohria S; Kishore H; Goyal P; Sehgal R; Sood A
J Gastroenterol Hepatol; 2021 Aug; 36(8):2107-2115. PubMed ID: 33464683
[TBL] [Abstract][Full Text] [Related]
20. A low FODMAP diet plus traditional dietary advice versus a low-carbohydrate diet versus pharmacological treatment in irritable bowel syndrome (CARIBS): a single-centre, single-blind, randomised controlled trial.
Nybacka S; Törnblom H; Josefsson A; Hreinsson JP; Böhn L; Frändemark Å; Weznaver C; Störsrud S; Simrén M
Lancet Gastroenterol Hepatol; 2024 Jun; 9(6):507-520. PubMed ID: 38643782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
